A clinical trial evaluating an investigational medication for children with Attention-Deficit/Hyperactivity Disorder (ADHD).
A new clinical trial for children with ADHD
Attention-Deficit/Hyperactivity Disorder is one of the most common neurodevelopmental disorders of childhood. It is usually first diagnosed in childhood and often lasts into adulthood. Children with ADHD may have trouble paying attention, controlling impulsive behaviors (may act without thinking about what the result will be), or be overly active. It is normal for children to have trouble focusing and behaving at one time or another. However, children with ADHD do not just grow out of these behaviors. The symptoms continue, can be severe, and can cause difficulty at school, at home, or with friends.
IPS Research is seeking participants for a clinical trial of an investigational medication for the treatment of ADHD in kids. If your child has been diagnosed with ADHD, they may be a candidate for this clinical trial.
This study is evaluating an investigational medication to learn if it is safe and effective for kids who have Attention-Deficit/Hyperactivity Disorder.
Your child may be eligible if he or she:
- Is 4 to 12 years old
- Has been diagnosed with ADHD
- Has a history of treatment with medication for ADHD
Qualified participants may receive:
- Study-related care and study drug at no cost
- Compensation for time and travel